Howland E. (Hal) Crosswell, MD, serves as Director of the Adolescent and Young Adult Hematology/Oncology Program and maintains a clinical practice at Bon Secours St. Francis Cancer Center in Greenville, South Carolina. He is double board certified in pediatrics and pediatric hematology/oncology. He is Chair of the AYA Committee of the Southeastern Community Oncology Research Consortium and is a member of the NCTN and NCORP AYA Working Groups. Dr. Crosswell is an affiliate member of the Hollings Cancer Center at The Medical University of South Carolina (MUSC) in Charleston, South Carolina. He also serves as Chief Medical Officer of KIYATEC, Inc., a Greenville-based life sciences company specializing in ex vivo 3D cell culture and tissue systems that more accurately replicate human biology and function. Dr. Crosswell is principal investigator for KIYATEC's NIH-funded research projects, including 2 NCI contracts focused on modelling breast, brain, and lung cancer, and developing a laboratory-based method for making clinical-grade platelets.
The ideas and viewpoints expressed in this commentary are those of the author and do not necessarily represent any policy, position, or program of NCCN.
Kaitlin N. Bomar, RN, BS, is a 2008 graduate of Clemson University's Nursing Program. She worked at Levine Children's Hospital in Charlotte, North Carolina, on their pediatric hematology, oncology, and bone marrow transplant unit before joining St. Francis's AYA team in 2012.
Nicole Vickery, RN, BSN, OCN, serves as Hematology Navigator and an AYA Navigator at Bon Secours St. Francis Cancer Center in Greenville, South Carolina.
Kristina Stoeppler-Biege, MS, RN, OCN, serves as Director of Clinical Operations at Bon Secours St. Francis Cancer Center in Greenville, South Carolina. As Director of Clinical Operations, she is responsible for Bon Secours hematology and oncology clinical practice, radiation oncology, finance, navigation, complementary medicine, support services, and clinical research. She received a Bachelor's Degree in biology and anthropology from Appalachian State University, and a Master's of Science in health sciences focusing on clinical research administration from George Washington University. She is also an oncology certified nurse.
Terra D. Spann, BS, OCN, is the Administrative Director of Oncology Services for Bon Secours St. Francis Health System. Ms. Spann has worked within the oncology program throughout the course of her career and has assisted in developing comprehensive oncology services within St. Francis. Her accomplishments include implementation of dedicated oncology infusion services, initiation of apheresis services, expansion of the Blood and Marrow Transplant unit, and oversight of multiple successful accreditations within the program, including the American College of Surgeons Commission on Cancer and the Foundation for the Accreditation of Cellular Therapy. Most recently, Ms. Spann served as the project lead for the design and development of the St. Francis Cancer Center, a freestanding center providing comprehensive care for oncology patients in the upstate.
Robert D. Siegel, MD, a board certified internist, hematologist, and medical oncologist, is the Oncology Program Director for the Bon Secours St. Francis Cancer Center. Prior to this, he had been a community-based oncologist with particular interest in quality improvement initiatives and cancer care delivery research. Dr. Siegel has held multiple roles in the American Board of Internal Medicine. He is currently a member of the organization's Board of Directors and is the Chair of the Medical Oncology Committee. He has served as the Cochair of the Quality of Care Subcommittee for the NCI Community Cancer Centers Program (NCCCP) and is currently on the executive committee for the Southeast Consortium for Oncology Research (SCOR). Dr. Siegel has served on ASCO committees and has worked with ASCO leadership in crafting alternatives to the ABIM practice improvement activities.